Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$871,872
-$68,457 QoQ
Shares Held
6,901
+2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,137
of 2,266 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. GILD ranks #7 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $871,872 | 6,901 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $940,329 | 6,747 | Shares | Sole | 2026-05-05 | |
| 2025-03-31 | $991,866 | 8,852 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $871,603 | 9,436 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $799,246 | 9,533 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $700,988 | 10,217 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $638,080 | 8,711 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $766,111 | 9,457 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $721,822 | 9,632 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $648,466 | 8,414 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $731,546 | 8,817 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $756,252 | 8,809 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $706,042 | 11,445 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $329,200 | 5,326 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $216,219 | 3,637 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $153,860 | 2,119 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $148,012 | 2,119 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $145,914 | 2,119 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $124,024 | 1,919 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $82,670 | 1,419 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $108,623 | 1,719 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||